Sort   by:  
 Page size 
UnknownProlonged therapy of advanced chronic hepatitis C with low-dose peginterferon.
Not available
S-EPMC2606037 | biostudies-literature
UnknownAssociation of polymorphisms in the hepatocyte growth factor gene promoter with keratoconus.
Not available
S-EPMC3208191 | biostudies-literature
UnknownIncidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.
Not available
S-EPMC3749922 | biostudies-literature
UnknownCoffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.
Not available
S-EPMC2783828 | biostudies-literature
UnknownAn IL28B genotype-based clinical prediction model for treatment of chronic hepatitis C.
Not available
S-EPMC3132753 | biostudies-literature
UnknownCoffee consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C.
Not available
S-EPMC3109110 | biostudies-literature
UnknownPredicting clinical outcomes using baseline and follow-up laboratory data from the hepatitis C long-term treatment against cirrhosis trial.
Not available
S-EPMC3718548 | biostudies-literature
UnknownPredicting cirrhosis and clinical outcomes in patients with advanced chronic hepatitis C with a panel of genetic markers (CRS7).
Not available
S-EPMC3215092 | biostudies-literature
UnknownIron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C.
Not available
S-EPMC3081953 | biostudies-literature
UnknownThe ongoing challenge of large anal cancers: prospective long term outcomes of intensity-modulated radiation therapy with concurrent chemotherapy.
Not available
S-EPMC5945520 | biostudies-literature
Sort   by:  
 Page size